author-photo

Christopher R. Porter

Virginia Mason Medical Center

188

Papers

2097

Citations

Citation Trend

Filter By

Papers (136) Sort By

Journal Conference Others

Contemporary trends in management of stage 1 seminoma.

2021 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (0)
Use of neoadjuvant chemotherapy in elderly patients with muscle invasive bladder cancer: A population-based study, 2006 to 2017.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Effect of PSA on equal treatment of high-risk patients.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Long-term health-related quality-of-life outcomes in a racially diverse cohort of prostate cancer patients receiving retropubic versus robotic prostatectomy.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy

2020 Urologic Oncology-seminars and Original Investigations
Show All
- Source
- Cite
- Save
Citations (1)
Long-term prospective health related quality of life (HRQoL) outcomes: Impact of active surveillance before treatment of low risk prostate cancer (PCa).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (51)
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy

2019 Prostate Cancer and Prostatic Diseases
Show All
- Source
- Cite
- Save
Citations (6)
Contemporary trends in treatment for low-risk prostate cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.

2019 Canadian Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)